In comparison to control samples, the increase in CD62L expression on immune cells in patients with NASH was found in CD14+CD68+ monocytes, CD4+ and CD8+ T cells (Figure 1E,F). Here, SELL is linked to metabolic dysfunction-associated steatohepatitis.